Status: Recruiting
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
This is a Pilot/Phase I clinical study of hyperpolarized 13C (HP 13C) pyruvate injection that includes the acquisition of magnetic resonance (MR) data performed on participants with meningioma to evaluate metabolism and aid in the non-invasive characterization of aggressive tumor behavior
Participants needed: 50
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Charlie Wang, MD, PhDUpdated: Aug 14, 2026Locations: 1
Eligibility criteria
Known (histopathologically confirmed) or presumed meningioma based on imaging wi... [+7]
Has any significant medical illnesses that in the investigator's opinion cannot... [+4]